Mass-selected site-specific core-fucosylation of ceruloplasmin in alcohol-related hepatocellular carcinoma

Journal of Proteome Research

Volumn 13, Issue 6, 2014, Pages 2887-2896

  Yin, Haidi ^a   Lin, Zhenxin ^a   Nie, Song ^a   Wu, Jing ^a   Tan, Zhijing ^a   Zhu, Jianhui ^a   Dai, Jianliang ^b   Feng, Ziding ^b   Marrero, Jorge ^c   Lubman, David M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

ceruloplasmin; Core fucosylation; hepatocellular carcinoma; site specific

Indexed keywords

ALPHA FETOPROTEIN; CERULOPLASMIN; GLYCOPEPTIDE; N ACETYLGLUCOSAMINE; PEPTIDE; TRYPSIN; TUMOR MARKER;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FUCOSYLATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; VERY ELDERLY; AMINO ACID SEQUENCE; BLOOD; CARCINOMA, HEPATOCELLULAR; CASE CONTROL STUDY; CHEMISTRY; COMPLICATION; DRINKING BEHAVIOR; GLYCOSYLATION; HEPATITIS B; HEPATITIS C; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; MOLECULAR WEIGHT; PROTEIN PROCESSING; TANDEM MASS SPECTROMETRY;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; AMINO ACID SEQUENCE; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CERULOPLASMIN; FEMALE; GLYCOSYLATION; HEPATITIS B; HEPATITIS C; HUMANS; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PROTEIN PROCESSING, POST-TRANSLATIONAL; ROC CURVE; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 84902106515     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500043k     Document Type: Article

References (24)

1. Kamangar, F.; Dores, G. M.; Anderson, W. F. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world J. Clin. Oncol. 2006, 24, 2137-2150
2. Llovet, J. M.; Burroughs, A.; Bruix, J. Hepatocellular carcinoma Lancet 2003, 362, 1907-1917
3. El-Serag, H. B. Hepatocellular carcinoma N. Engl. J. Med. 2011, 365, 1118-1127
4. Trevisani, F.; D'Intino, P. E.; Morselli-Labate, A. M.; Mazzella, G.; Accogli, E.; Caraceni, P.; Domenicali, M.; De Notariis, S.; Roda, E.; Bernardi, M. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status J. Hepatol. 2001, 34, 570-575
5. Nakamura, S.; Nouso, K.; Sakaguchi, K.; Ito, Y. M.; Ohashi, Y.; Kobayashi, Y.; Toshikuni, N.; Tanaka, H.; Miyake, Y.; Matsumoto, E.; Shiratori, Y. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size Am. J. Gastroenterol. 2006, 101, 2038-2043
6. Marrero, J. A.; Feng, Z. D.; Wang, Y. H.; Nguyen, M. H.; Befeler, A. S.; Roberts, L. R.; Reddy, K. R.; Harnois, D.; Llovet, J. M.; Normolle, D.; Dalhgren, J.; Chia, D.; Lok, A. S.; Wagner, P. D.; Srivastava, S.; Schwartz, M. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma Gastroenterology 2009, 137, 110-118
7. Lok, A. S.; Sterling, R. K.; Everhart, J. E.; Wright, E. C.; Hoefs, J. C.; Di Bisceglie, A. M.; Morgan, T. R.; Kim, H. Y.; Lee, W. M.; Bonkovsky, H. L.; Dienstag, J. L.; Grp, H. C. T. Des-gamma-carboxyprothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma Gastroenterology 2010, 138, 493-502
8. Lin, Z. X.; Yin, H. D.; Lo, A.; Ruffin, M. T.; Anderson, M. A.; Simeone, D. M.; Lubman, D. M. Label-free relative quantification of alpha-2-macroglobulin site-specific core-fucosylation in pancreatic cancer by LC-MS/MS. Electrophoresis [Online early access]. DOI: 10.1002/elps.201300376. Published Online: Dec 27, 2013.
9. Ahn, J. M.; Sung, H. J.; Yoon, Y. H.; Kim, B. G.; Yang, W. S.; Lee, C.; Park, H. M.; Kim, B. J.; Kim, B. G.; Lee, S. Y.; An, H. J.; Cho, J. Y. Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer Mol. Cell Proteomics 2013, 13, 30-48
10. Sato, Y.; Nakata, K.; Kato, Y.; Shima, M.; Ishii, N.; Koji, T.; Taketa, K.; Endo, Y.; Nagataki, S. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein N. Engl. J. Med. 1993, 328, 1802-1806
11. Nakagawa, T.; Miyoshi, E.; Yakushijin, T.; Hiramatsu, N.; Igura, T.; Hayashi, N.; Taniguchi, N.; Kondo, A. Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients J. Proteome Res. 2008, 7, 2222-2233
12. Toyoda, H.; Kumada, T.; Tada, T.; Kaneoka, Y.; Maeda, A.; Kanke, F.; Satomura, S. Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL Cancer Sci. 2011, 102, 1025-1031
13. Comunale, M. A.; Rodemich-Betesh, L.; Hafner, J.; Wang, M.; Norton, P.; Di Bisceglie, A. M.; Block, T.; Mehta, A. Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma PLoS One 2010, 5, e12419
14. Yildirim, A.; Meral, M.; Kaynar, H.; Polat, H.; Ucar, E. Y. Relationship between serum levels of some acute-phase proteins and stage of disease and performance status in patients with lung cancer Med. Sci. Monit. 2007, 13, CR195-CR200
15. Hanas, J. S.; Hocker, J. R.; Cheung, J. Y.; Larabee, J. L.; Lerner, M. R.; Lightfoot, S. A.; Morgan, D. L.; Denson, K. D.; Prejeant, K. C.; Gusev, Y.; Smith, B. J.; Hanas, R. J.; Postier, R. G.; Brackett, D. J. Biomarker identification in human pancreatic cancer sera Pancreas 2008, 36, 61-69
16. Walker, C.; Gray, B. N. Acute-phase reactant proteins and carcinoembryonic antigen in cancer of the colon and rectum Cancer 1983, 52, 150-154
17. Liu, Y. S.; He, J. T.; Li, C.; Benitez, R.; Fu, S.; Marrero, J.; Lubman, D. M. Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations J. Proteome Res. 2010, 9, 798-805
18. El-Serag, H. B. Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology 2012, 142, 1264-1273
19. Morgan, T. R.; Mandayam, S.; Jamal, M. M. Alcohol and hepatocellular carcinoma Gastroenterology 2004, 127, S87-96
20. Hussain, S. P.; Schwank, J.; Staib, F.; Wang, X. W.; Harris, C. C. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer Oncogene 2007, 26, 2166-2176
21. Tarentino, A. L.; Plummer, T. H. Enzymatic deglycosylation of asparagine-linked glycans: purification, properties, and specificity of oligosaccharide-cleaving enzymes from Flavobacterium meningosepticum Methods Enzymol. 1994, 230, 44-57
22. Huttenhain, R.; Surinova, S.; Ossola, R.; Sun, Z.; Campbell, D.; Cerciello, F.; Schiess, R.; Bausch-Fluck, D.; Rosenberger, G.; Chen, J. C.; Rinner, O.; Kusebauch, U.; Hajduch, M.; Moritz, R. L.; Wollscheid, B.; Aebersold, R. N-Glycoprotein SRMAtlas: a resouce of mass spectrometeric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications Mol. Cell. Proteomics 2013, 12, 1005-1016
23. Stavenhagen, K.; Hinneburg, H.; Thaysen-Andersen, M.; Hartmann, L.; Silva, D. V.; Fuchser, J.; Kaspar, S.; Rapp, E.; Seeberger, P. H.; Kolarich, D. Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: an evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides J. Mass Spectrom. 2013, 48, 627-639
24. Deshpande, N.; Jensen, P. H.; Packer, N. H.; Kolarich, D. GlycoSpectrumScan: fishing glycopeptides from MS spectra of protease digests of human colostrum sIgA J. Proteome Res. 2010, 9, 1063-1075